bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 27, 2024
Abstract
Background
Amyotrophic
lateral
sclerosis
(ALS)
is
a
rapidly
progressing
neurodegenerative
disorder
with
minimally
effective
treatment
options.
An
important
hurdle
in
ALS
drug
development
the
non-invasive
therapeutic
access
to
motor
cortex
currently
limited
by
presence
of
blood-brain
barrier
(BBB).
Focused
ultrasound
and
microbubble
(FUS
+MB
)
an
emerging
technology
that
was
successfully
used
patients
temporarily
open
cortical
BBB.
However,
FUS
-mediated
delivery
across
patients’
BBB
has
not
yet
been
reported.
Similarly,
effects
on
human
cells
remain
unexplored.
Methods
Here
we
established
first
-compatible,
fully-human
patient-cell-derived
model
based
induced
brain
endothelial-like
(iBECs)
study
anti-TDP-43
antibody
bioeffects
vitro
.
Results
Generated
iBECs
recapitulated
disease-specific
hallmarks
pathology,
including
changes
integrity,
permeability
TDP-43
proteinopathy.
Our
results
also
identified
differences
between
sporadic
familial
(
C9orf72
expansion
carrying)
reflecting
patient
heterogeneity
associated
disease
subgroups.
Studies
these
models
revealed
successful
iBEC
monolayer
opening
lack
adverse
cellular
This
accompanied
molecular
expression
tight
adherens
junction
markers,
transporter
inflammatory
mediators,
generating
transient
specific
responses.
Additionally,
demonstrated
increase
(2.7-fold)
(1.9-fold)
providing
proof-of-concept
evidence
can
be
enhance
large
molecule
therapeutics
model.
Conclusions
Together,
our
describes
characterisation
responses
provides
platform
for
screening
Cell Reports,
Journal Year:
2024,
Volume and Issue:
43(7), P. 114421 - 114421
Published: June 27, 2024
TDP-43
protein
is
dysregulated
in
several
neurodegenerative
diseases,
which
often
have
a
multifactorial
nature
and
may
extrinsic
stressors
as
"second
hit."
undergoes
reversible
nuclear
condensation
stressed
cells
including
neurons.
Here,
we
demonstrate
that
stress-inducible
condensates
are
RNA-depleted,
non-liquid
assemblies
distinct
from
the
known
bodies.
Their
formation
requires
oligomerization
ATP
inhibited
by
RNA.
Using
confocal
nanoscanning
assay,
find
amyotrophic
lateral
sclerosis
(ALS)-linked
mutations
alter
stress-induced
changing
its
affinity
to
liquid-like
ribonucleoprotein
assemblies.
Stress-induced
transiently
inactivates
TDP-43,
leading
loss
of
interaction
with
binding
partners
function
splicing.
Splicing
changes
especially
prominent
persisting
for
STMN2
RNA,
becomes
rapidly
depleted
early
during
stress.
Our
results
point
pathological
nucleus
support
therapeutic
modulation
stress
response
ALS.
Frontiers in Aging Neuroscience,
Journal Year:
2025,
Volume and Issue:
17
Published: Jan. 29, 2025
Genetic
diversity
in
the
apolipoprotein
E
(ApoE)
gene
has
been
identified
as
major
susceptibility
genetic
risk
factor
for
sporadic
Alzheimer’s
disease
(SAD).
Specifically,
ApoEε4
allele
is
a
significant
SAD,
while
ApoEε2
provides
protection
compared
to
more
common
ApoEε3
allele.
This
review
discusses
role
of
ApoE
AD
and
other
neurodegenerative
disorders.
ApoE,
cholesterol
transport
protein,
influences
several
pathways
involved
neurodegeneration,
particularly
AD.
Beyond
its
established
amyloid
β
-protein
(Aβ)
metabolism
deposition,
also
impacts
tau
pathology,
microglial
response
The
aims
provide
an
updated
overview
ApoE’s
diverse
roles,
emphasizing
involvement
Aβ
clearance
through
receptors.
It
covers
influence
diseases
like
Parkinson’s
(PD),
amyotrophic
lateral
sclerosis
(ALS),
frontotemporal
lobar
degeneration
(FTLD),
Huntington’s
(HD),
vascular
dementia
(VD),
multiple
(MS).
New
research
highlights
interaction
between
presenilin
(PS),
suggesting
connections
familial
(FAD)
SAD.
explores
protective
effects
mutations
against
ApoE4-induced
tauopathy,
neuroinflammation.
insights
from
this
comprehensive
update
could
indeed
lead
new
therapeutic
strategies
diseases.
Alzheimer s & Dementia,
Journal Year:
2025,
Volume and Issue:
21(2)
Published: Feb. 1, 2025
Abstract
The
characteristic
events
in
neurodegenerative
diseases
(NDDs)
encompass
protein
misfolding,
aggregation,
accumulation,
and
their
related
cellular
dysfunction,
synaptic
function
loss.
While
distinct
proteins
are
implicated
the
pathological
processes
of
different
NDDs,
process
misfolding
aggregation
remains
notably
similar
across
various
conditions.
Specifically,
undergo
into
beta‐folded
(β‐folded)
conformation,
resulting
formation
insoluble
amyloid
proteins.
Despite
advancements
comprehending
certain
facets
this
intricate
remain
incompletely
elucidated.
In
recent
years,
concept
that
long
non‐coding
RNAs
(lncRNAs)
contribute
to
has
gained
recognition.
LncRNAs
influence
aggregates
by
facilitating
overexpression
through
regulation
gene
transcription
translation,
inhibiting
degradation
via
lysosomal
autophagic
pathways,
targeting
aberrant
modifications
phase
transitions
A
better
understanding
relationship
between
lncRNAs
is
an
important
step
dissecting
underlying
molecular
mechanisms
will
discovery
new
therapeutic
targets
strategies.
Highlights
NDDs
marked
leading
dysfunction
loss
function.
being
involved
β‐folded
conformations
forming
consistent
role
attention,
as
they
regulate
inhibit
degradation,
target
modifications.
Understanding
link
crucial
for
uncovering
developing
targets.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 141677 - 141677
Published: March 1, 2025
Transactive
response
(TAR)
DNA-binding
protein
43
(TDP-43)
is
a
critical
RNA/DNA-binding
involved
in
various
cellular
processes,
including
RNA
splicing,
transcription
regulation,
and
stability.
Mislocalization
aggregation
of
TDP-43
the
cytoplasm
are
key
features
pathogenesis
several
neurodegenerative
diseases,
amyotrophic
lateral
sclerosis
(ALS),
frontotemporal
dementia
(FTD),
Alzheimer's
disease
(AD).
This
review
provides
comprehensive
retrospective
prospective
analysis
research,
highlighting
structural
insights,
significant
milestones,
evolving
understanding
its
physiological
pathological
functions.
We
delineate
five
major
stages
from
initial
discovery
as
hallmark
neurodegeneration
to
recent
advances
liquid-liquid
phase
separation
(LLPS)
behavior
interactions
with
processes.
Furthermore,
we
assess
therapeutic
strategies
targeting
pathology,
categorizing
approaches
into
direct
indirect
interventions,
alongside
modulating
aberrant
LLPS.
propose
that
future
research
will
focus
on
three
areas:
polymorphisms
for
disease-specific
therapeutics,
exploring
dual
temporal-spatial
modulation
TDP-43,
advancing
nano-therapy.
More
importantly,
emphasize
importance
TDP-43's
functional
repertoire
at
mesoscale,
which
bridges
molecular
functions
broader
offers
foundational
framework
development.
Nucleic Acids Research,
Journal Year:
2024,
Volume and Issue:
52(9), P. 5301 - 5319
Published: Feb. 21, 2024
Insoluble
cytoplasmic
aggregate
formation
of
the
RNA-binding
protein
TDP-43
is
a
major
hallmark
neurodegenerative
diseases
including
Amyotrophic
Lateral
Sclerosis.
localizes
predominantly
in
nucleus,
arranging
itself
into
dynamic
condensates
through
liquid-liquid
phase
separation
(LLPS).
Mutations
and
post-translational
modifications
can
alter
condensation
properties
TDP-43,
contributing
to
transition
liquid-like
biomolecular
solid-like
aggregates.
However,
date
it
has
been
challenge
study
dynamics
this
process
vivo.
We
demonstrate
live
imaging
that
human
undergoes
nuclear
spinal
motor
neurons
living
animal.
deficiencies
as
well
lead
aberrant
altered
compartmentalization.
Single-molecule
tracking
revealed
an
mobility
profile
for
deficient
TDP-43.
Overall,
these
results
provide
critically
needed
vivo
characterization
condensation,
important
regulatory
mechanism
accessibility,
identify
molecular
how
functional
be
regulated.
Translational Neurodegeneration,
Journal Year:
2024,
Volume and Issue:
13(1)
Published: June 3, 2024
TDP-43
proteinopathies
are
a
heterogeneous
group
of
neurodegenerative
disorders
that
share
the
presence
aberrant,
misfolded
and
mislocalized
deposits
protein
TDP-43,
as
in
case
amyotrophic
lateral
sclerosis
some,
but
not
all,
pathological
variants
frontotemporal
dementia.
In
recent
years,
many
other
diseases
have
been
reported
to
primary
or
secondary
proteinopathy,
such
Alzheimer's
disease,
Huntington's
disease
recently
described
limbic-predominant
age-related
encephalopathy,
highlighting
need
for
new
accurate
methods
early
detection
proteinopathy
help
on
stratification
patients
with
overlapping
clinical
diagnosis.
Currently,
remains
post-mortem
pathologic
Although
main
aim
is
determine
central
nervous
system
(CNS),
ubiquitous
expression
biofluids
cells
outside
CNS
facilitates
use
accessible
target
tissues
might
reflect
potential
alterations
brain.
this
review,
we
describe
developments
proteinopathies,
their
implications
diagnosis
future
treatments.
Fluids and Barriers of the CNS,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: Aug. 13, 2024
Amyotrophic
lateral
sclerosis
(ALS)
is
a
rapidly
progressing
neurodegenerative
disorder
with
minimally
effective
treatment
options.
An
important
hurdle
in
ALS
drug
development
the
non-invasive
therapeutic
access
to
motor
cortex
currently
limited
by
presence
of
blood-brain
barrier
(BBB).
Focused
ultrasound
and
microbubble
(FUS
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 30, 2025
Understanding
the
interaction
between
nanomaterials
and
cellular
structures
is
crucial
for
nanoparticle
applications
in
biomedicine.
We
have
identified
a
subtype
of
stress
granules,
called
nanomaterial-provoked
granules
(NSGs),
induced
by
gold
nanorods
(AuNRs).
These
NSGs
differ
from
traditional
SGs
their
physical
properties
biological
functions.
Uptake
AuNRs
causes
reactive
oxygen
species
accumulation
protein
misfolding
cell,
leading
to
NSG
formation.
Physically,
gel-like
core
liquid-like
shell,
influenced
positively
HSP70
negatively
HSP90
ubiquitin-proteasome
system.
promote
assembly
interacting
with
G3BP1,
reducing
energy
needed
liquid-liquid
phase
separation
(LLPS).
impact
functions
affecting
mRNA
surveillance
activating
Adenosine
5'-monophosphate
(AMP)-activated
kinase
signaling,
response.
Our
study
highlights
role
LLPS
nanomaterial
metabolism
suggests
as
potential
targets
drug
delivery
strategies,
advancing
field
nanomedicine.